Arcadia BiosciencesRKDA
13F holders, Q3 2024 (September 30)13holders +2
3new positions
1sold out
$2.76avg. 13F price*
At the end of Q3 2024, 13 institutions reported holding Arcadia Biosciences Inc. (RKDA) in their 13F filings, up 2 from Q2 2024. 3 opened new positions and 1 sold out. The largest holders were Mariner, LLC ($68K), Vanguard Group Inc. ($39K) and State Street Corp. ($34K).
- Company
- Arcadia Biosciences Inc.
- CUSIP
- 039014303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $69K |
| Exits | 1 | $0 |
All 13F filers, Q2 2024 → Q3 2024: 25,244 shares bought and 34 shares sold, net +25,210 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Mariner, LLC | 0.00% | New | 25,000 | $68K |
| Vanguard Group Inc. | 0.00% | No change | 14,038 | $39K |
| State Street Corp. | 0.00% | No change | 12,146 | $34K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -1.1% | 1,764 | $5K |
| Morgan Stanley | 0.00% | No change | 607 | $2K |
| UBS Group AG | 0.00% | New | 239 | $652 |
| Osaic Holdings, Inc. | 0.00% | Reduce -14.8% | 75 | $205 |
| Group One Trading LLC | 0.00% | No change | 18 | $50 |
| Bank of America Corp. | 0.00% | No change | 11 | $30 |
| US Bancorp \de | 0.00% | No change | 5 | $14 |
| Assetmark, Inc. | 0.00% | New | 5 | $14 |
| Oliver Lagore Vanvalin Investment Group | 0.00% | No change | 4 | $11 |
| Harbour Investments, Inc. | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is RKDA's weight in each manager's 13F, not the share of Arcadia Biosciences Inc. the manager owns.